Psychedelic

The very word makes me think, paisley, tie-dye, taking trips and getting high.

But the idea of getting magic mushrooms from real medical doctors?

Well, a few decades ago if you told me that, I would ask you, more do you smoking?

The current reality?

Psychedelic drugs are still classified as schedule one drugs.

Everyone drugs or drugs with no current, accepted medical use and a high potential for abuse.

But as regulations around these drugs are beginning to loosen, they're becoming accepted treatments

for a host of mental health issues.

For real focus is on transforming mental health care.

And that's something that really needs to happen for lots of people.

That's George Goldsmith.

He's the CEO of Compass Pathways.

A biotech company that's been investing money in research on psychedelics.

The goal to cash in on the potential benefits psychedelics that have for mental health.

Compass is one of these major biofarma players that has entered the scene that's really

focused on psychedelic drugs.

They were for a time the highest valued publicly traded company that specializes in psychedelics.

Which I think to me is even a weird thing to say at all that there's any publicly traded

psychedelics companies these days.

And that's John Simley.

He covers psychedelics and the pharmaceutical industry.

...